Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Echinobase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Echinobase
ECB-ART-50106
Russ Chem Bull 2013 Jan 01;623:836-843. doi: 10.1007/s11172-013-0113-2.
Show Gene links Show Anatomy links

Synthesis and antineoplastic properties of (1H-1,2,3-triazol-1-yl)furazans.

Kulikov AS , Epishina MA , Batog LV , Rozhkov VY , Makhova NN , Konyushkin LD , Semenova MN , Semenov VV .


???displayArticle.abstract???
A method of 3-amino-4-[5-aryl(heteroaryl)-1H-1,2,3-triazol-1-yl)]furazan synthesis was optimized. Condensation of these compounds with 2,5-dimethoxytetrahydrofuran resulted in a series of previously unknown 4-[5-aryl(heteroaryl)-1H-1,2,3-triazol-1-yl)]-3-(pyrrol-1-yl)furazans. All target compounds were evaluated for both antimitotic microtubule destabilizing effect in a phenotypic sea urchin embryo assay and cytotoxicity in a panel of 60 human cancer cell lines. Pyrrolyl derivatives of triazolylfurazans were determined as antiproliferative compounds. The most potent microtubule targeting compounds 7a and 7e are of interest for further trials as antineoplastic agents.

???displayArticle.pubmedLink??? 32214776
???displayArticle.pmcLink??? PMC7088692
???displayArticle.link??? Russ Chem Bull



References [+] :
Beale, Increased endothelial cell selectivity of triazole-bridged dihalogenated A-ring analogues of combretastatin A-1. 2012, Pubmed